The Joint Blog
FEBRUARY 24, 2021
Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s? They made it clear that no evidence is available and that there are real potential risks to treatment. had described some form of significant benefit from the treatment.
Canna Care Docs
NOVEMBER 23, 2020
Medicinal cannabis was already approved in Montana in 2004. Medicinal cannabis is typically not restricted to adults 21 and older, allowing younger patients seeking treatment to obtain the prescriptions they need. . The passing initiative legalizes cannabis prescriptions for 22 medical conditions. Schedule a virtual consultation today.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
OCTOBER 1, 2020
In 2004, cannabis was reclassified as a class C drug but was reinstated to Class B in 2008 following Prime Minister Gordon Brown’s decision to go against the advice offered up by the Advisory Council on the Misuse of Drugs. . A prescription for medical cannabis can be made once all other treatment options have been exhausted.
Greencamp
AUGUST 16, 2018
The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.
Cannabis Law Report
NOVEMBER 24, 2021
Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Refractory paediatric epilepsy. Conclusions.
Cannabis Law Report
JULY 12, 2019
Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.
The Cannigma
OCTOBER 8, 2021
The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009. The physician will look at the patient’s medical record and ask why previous treatments didn’t work and how the health condition affects the patient’s life.
Expert insights. Personalized for you.
55 
Let's personalize your content